Tumor suppressor CD99 is downregulated in plasma cell neoplasms lacking CCND1 translocation and distinguishes neoplastic from normal plasma cells and B-cell lymphomas with plasmacytic differentiation from primary plasma cell neoplasms-Reference-Cited by-同舟云学术

Tumor suppressor CD99 is downregulated in plasma cell neoplasms lacking CCND1 translocation and distinguishes neoplastic from normal plasma cells and B-cell lymphomas with plasmacytic differentiation from primary plasma cell neoplasms

Published:2018-02-05 Issue:6 Volume:31 Page:881-889
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Gao Qi,Yellapantula Venkata,Fenelus Maly,Pichardo Janine,Wang Lu,Landgren Ola,Dogan Ahmet,Roshal Mikhail

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/s41379-018-0011-0.pdf

Reference36 articles.

1. Zucchini C, Manara MC, Pinca RS, et al. CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity. Oncogene. 2014;33:1912–21.

2. Manara MC, Bernard G, Lollini PL, et al. CD99 acts as an oncosuppressor in osteosarcoma. Mol Biol Cell. 2006;17:1910–21.

3. Chung SS, Eng WS, Hu W et al. CD99 is a therapeutic target on disease stem cells in myeloid malignancies. Sci. Trans. Med. 2017;9.

4. Imbert AM, Belaaloui G, Bardin F, et al. CD99 expressed on human mobilized peripheral blood CD34+ cells is involved in transendothelial migration. Blood. 2006;108:2578–86.

5. Sullivan DP, Seidman MA, Muller WA. Poliovirus receptor (CD155) regulates a step in transendothelial migration between PECAM and CD99. Am J Pathol. 2013;182:1031–42.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatial transcriptomics unveils thein situcellular and molecular hallmarks of the lung in fatal COVID-19;2024-07-04

2. CD99 tumor associated antigen is a potential target for antibody therapy of T-cell acute lymphoblastic leukemia;Exploration of Targeted Anti-tumor Therapy;2024-02-19

3. Cell adhesion molecule CD99 in cancer immunotherapy;Current Molecular Medicine;2022-10-07

4. PD ‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome;Cytometry Part B: Clinical Cytometry;2022-04-22

5. References;Flow Cytometry of Hematological Malignancies;2021-04-06